Overview

Study of SB939 in Subjects With Myelofibrosis

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if SB939 can help to control myelofibrosis. The safety of this drug will also be studied.
Phase:
Phase 2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborator:
S*BIO
Treatments:
Histone Deacetylase Inhibitors